Directors’ Dealings

Under § 15a of the German Securities Trading Act (WpHG), the Members of the Management and Supervisory Boards of MorphoSys AG, as well as persons with a “close relationship” to such members, are obligated to report trading in MorphoSys stock to the German Federal Financial Supervisory Authority (BaFin). In addition to purchase and sales transactions involving MorphoSys stock, securities transactions relating to MorphoSys shares (e.g. purchase or sale of options options or convertible bonds for MorphoSys stocks) must also be reported. The granting of options based on employment agreements or as a component of compensation are not subject to reporting requirements. All transactions have to be published unless the total value of these tradings executed by such person within one calendar year does not exceed EUR 5,000.

Notes:
Participants in the MorphoSys stock option and/or convertible bonds programs who choose to “exercise and sell” receive the difference between the so-called exercise price (price determined at the time of issuing the options) and the Xetra closing price of the MorphoSys stock on the day of exercise, as a taxable income.

All reported transactions of MorphoSys AG are published via GlobeNewswire.


Declared Security Transactions

Date

Name and Function

Transaction Type, Number & Security

Date, Place, Price & Transaction Volume

Jun 16, 2014Dr. Arndt Schottelius, CDOSale; 11.000 convertible bonds were converted into MorphoSys AG shares and subsequently soldJune 13, 2014
Frankfurt (XETRA), EUR 68.1948
EUR 750,142.80
Jun 16, 2014Dr. Arndt Schottelius, CDOSale; 22.000 convertible bonds were converted into MorphoSys AG shares and subsequently soldJune 12, 2014
Frankfurt (XETRA), EUR 69.7598
EUR 1,534,715.60
Mar 28, 2014Jens Holstein, CFOSale of 4,500 MorphoSys AG sharesMarch 26, 2014
Frankfurt (XETRA), EUR 65.52
EUR 294,826.30
Mar 14, 2014Dr. Marc Cluzel (via C&F Consulting), Member of the Supervisory BoardPurchase of 500 MorphoSys AG sharesMarch 13, 2014
Frankfurt (XETRA), EUR 67.60
EUR 38,802.00
Nov 25, 2013Dr. Simon Moroney, CEO

Purchase; 33,000 stock options were converted into MorphoSys AG shares; Dr. Moroney is holding the shares received

November 19, 2013
off-exchange, EUR 12.81
EUR 422,730.00
Nov 25, 2013Dr. Simon Moroney, CEOSale; 28,300 stock options were converted into MorphoSys AG shares and subsequently soldNovember 19, 2013
Frankfurt (XETRA), EUR 55.85
EUR 1,580,555.00
Nov 25, 2013Dr. Simon Moroney, CEOSale; 860 stock options were converted into MorphoSys AG shares and subsequently soldNovember 20, 2013
Frankfurt (XETRA), EUR 55.00
EUR 47,300.00
Nov 25, 2013Dr. Simon Moroney, CEOSale; 18,840 stock options were converted into MorphoSys AG shares and subsequently soldNovember 21, 2013
Frankfurt (XETRA), EUR 54.39
EUR 1,024,707.60
Sep 23, 2013Karin Eastham, Member of the Supervisory BoardPurchase of 1,000 MorphoSys AG shares

September 20, 2013

Frankfurt, USD 76.68

USD 76,680.00

Jul 18, 2013Dr. Simon Moroney, CEOSale; 110,445 stock options were converted into MorphoSys AG shares and subsequently sold

July 16, 2013

off-exchange, EUR 49.00

EUR 5,411,805.00

Jul 18, 2013Dr. Arndt Schottelius, CDOSale; 90,000 stock options were converted into MorphoSys AG shares and subsequently sold

July 16, 2013

off-exchange, EUR 49.00

EUR 4,410,000.00

Jul 18, 2013Dr. Marlies Sproll, CSOSale; 46,002 stock options were converted into MorphoSys AG shares and subsequently sold

July 16, 2013

off-exchange, EUR 49.00

EUR 2,254,098.00

Jul 18, 2013Dr. Marlies Sproll, CSOSale; 36,600 stock options were converted into MorphoSys AG shares and subsequently sold

July 16, 2013

off-exchange, EUR 49.00

EUR 1,793,400.00

Jul 18, 2013Dr. Marlies Sproll, CSOPurchase; 20,265 stock options were converted into MorphoSys AG shares; Dr. Sproll is holding the shares received

July 16, 2013

off-exchange, EUR 13.03

EUR 264,052.95

Jul 10, 2013

Dr. Gerald Möller,

Chairman of the Supervisory Board

Purchase of 1,500 MorphoSys AG shares

July 10, 2013

Frankfurt, EUR 50.65

EUR 75,975.00

Jun 13, 2012Jens Holstein, CFOPurchase of 1,000 MorphoSys AG shares

June 08, 2012

XETRA, EUR 17.00

EUR 17,000.00

Jun 13, 2012Jens Holstein, CFOPurchase of 500 MorphoSys AG shares

June 07, 2012

XETRA, EUR 17.10

EUR 8,550.00

Holdings of the Boards as of March 31, 2014

 

Shares

Stock Options

Convertible Bonds

Performance Shares

Management Board

    

Dr. Simon Moroney

452,885

0

147,186

48,676

Mr. Jens Holstein

2,000

0

90,537

33,339

Dr. Arndt Schottelius

2,000

0

93,537

33,339

Dr. Marlies Sproll

27,370

0

93,537

33,339

Supervisory Board

    

Dr. Gerald Möller (Chairman)

9,000

0

0

0

Dr. Geoffrey Vernon

0000

Dr. Walter Blättler

2,019

0

0

0

Dr. Daniel Camus

0

0

0

0

Dr. Marc Cluzel

500

0

0

0

Karin Eastham1,000000

For a detailed description of the stock option schemes and convertible bonds programs for the employees of MorphoSys Group, we refer to the latest Consolidated Financial Statements.